Quest Partners LLC Mirum Pharmaceuticals, Inc. Transaction History
Quest Partners LLC
- $753 Billion
- Q4 2024
A detailed history of Quest Partners LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 1,829 shares of MIRM stock, worth $93,388. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,829
Previous 171
969.59%
Holding current value
$93,388
Previous $6.67 Million
1034.04%
% of portfolio
0.01%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding MIRM
# of Institutions
196Shares Held
54.2MCall Options Held
177KPut Options Held
167K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$335 Million13.79% of portfolio
-
Janus Henderson Group PLC London, X04.48MShares$229 Million0.09% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.45MShares$176 Million2.37% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$165 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.08MShares$157 Million3.81% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.88B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...